| 翻訳と辞書 |
| pralatrexate ： ウィキペディア英語版 |
pralatrexate
Pralatrexate (brand name Folotyn) is an anti-cancer therapy.〔(), Allos Therapeutics Press Release, “Allos Therapeutics' Pralatrexate Demonstrates Anticancer Activity in Multiple Cancer Cell Lines”.〕 It is the first drug approved as a treatment for patients with relapsed or refractory peripheral T-cell lymphoma, or PTCL〔(), Allos Therapeutics Press Release, “Allos Therapeutics' FOLOTYN(TM) First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma”.〕 — a biologically diverse group of aggressive blood cancers that have a poor prognosis.〔
==Approval==
Folotyn was approved by the U.S. Food and Drug Administration (FDA) in September 2009 under the FDA’s accelerated approval,〔 which allows for earlier approval of drugs that meet unmet medical needs.〔(), FDA, “Fast Track, Accelerated Approval and Priority Review”.〕 Pralatrexate injection is marketed in the U.S. under the name Folotyn by Spectrum Pharmaceuticals.〔 Clinical trials are currently underway to explore the potential of Folotyn in other blood related cancers and solid tumors.〔(), Allos Therapeutics, “Allos Therapeutics, Inc. Q1 2010 Earnings Call Transcript”.〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「pralatrexate」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|